Inisync combination tablets, manufactured by Teijin Pharma, contain Alogliptin benzoate and Metformin hydrochloride, YJ code 3969105F1023, 1 tablet. This medication is typically used for the management of type 2 diabetes.
Inisync combination tablets
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).